Search by Drug Name
A B C D E F G H I J K L M N O P Q R S T U V W X Y ZClinical Trials for ANGIOMAX RTU
- Safety and Efficacy of Bivalirudin Versus Heparin for Systemic Anticoagulation in Extracorporeal Membrane Oxygenation
- Clinical Study of Bivalirudin for Percutaneous Coronary Intervention (PCI)
- A Single Center Diagnostic, Cross-sectional Study of Coronary Microvascular Dysfunction
- Bivalirudin Infusion for Ventricular Infarction Limitation
- ENDOvascular Interventions With AngioMAX: The ENDOMAX Trial
- Effects Contrast on Platelet Activity, Thrombosis and Fibrinolysis in Patients Undergoing Coronary Angiography
- Angiomax® or Unfractionated Heparin for Patients Undergoing Percutaneous Coronary Intervention
- European Ambulance Acute Coronary Syndrome (ACS) Angiography Trial
- EArly Discharge After Transradial Stenting of CoronarY Arteries in High-Risk Patients of Bleeding
- The UNBLOCK Study: Utilization of Bivalirudin On Clots in Kids
- Bivalirudin as a Procedural Anticoagulant in Pediatrics
- Switching From Fondaparinux to Bivalirudin or Unfractionated Heparin in ACS Patients Undergoing PCI
- Harmonizing Outcomes With Revascularization and Stents in Acute Myocardial Infarction
- Comparison of Angiomax Versus Heparin in Acute Coronary Syndromes (ACS)
- Comparing Angiomax to Heparin With Protamine in Patients Undergoing Cardiopulmonary Bypass (CPB)
- Angiomax in Patients With HIT/HITTS Type II Undergoing CPB
- Comparing Angiomax to Heparin With Protamine Reversal in Patients OPCAB
- Angiomax in Patients With HIT/HITTS Type II Undergoing Off-Pump Coronary Artery Bypass Grafting (CABG) (CHOOSE)
- Study Of Angiomax In Infants Under Six Months With Thrombosis
Clinical trials list
click for details